[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349440-105":59,"doc-detail-349440-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mpoint-an-epigenetics-driven-workflow-for-integrative-multi-level-proteomics","MPOInt: An Epigenetics-Driven Workflow for Integrative Multi-Level Proteomics","","Proteomics reveals systems that regulate cell behavior and helps define epigenetic states linked to health and disease. Integrating complementary proteomics modalities—total, phospho, and epi—enables a coherent view of how biological systems respond to stimuli. However, most existing data are captured separately and require custom, time-intensive bioinformatics to perform integrative analyses. The MPOInt pipeline and its R package provide flexible modules that combine multi-dimensional views with minimal effort, including integration of histone proteomes with known epigenetic effectors and clinical datasets. This enables identification of candidate pathways driving aggressive cancers, adds clinical context to hard-to-interpret proteomic data, and generates epigenetic-centered networks for each dataset.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mpoint-an-epigenetics-driven-workflow-for-integrative-multi-level-proteomics/349440/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mpoint-an-epigenetics-driven-workflow-for-integrative-multi-level-proteomics/349440.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the MPOInt workflow address in proteomics research?","Question",{"text":112,"@type":113},"It addresses the limitation that proteomics data are often collected in separate modalities with limited insight into how regulatory systems interact, and that integrative analysis typically requires custom, time-consuming bioinformatics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does MPOInt integrate multiple proteomics modalities?",{"text":117,"@type":113},"It combines total, phospho, and epi proteomics into a multi-dimensional view and can integrate histone proteome data with known epigenetic effectors using its flexible pipeline modules and associated R package.",{"name":119,"@type":110,"acceptedAnswer":120},"How can MPOInt use clinical data to support biological discovery?",{"text":121,"@type":113},"By applying the tool to pre-existing clinical datasets, it identifies pathways that may be targets in driving aggressive cancers, including treatment-resistant estrogen receptor-positive breast cancer, and produces epigenetic-centered networks for each dataset.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349440,1790694589,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","This article is licensed under CC-BY 4.0   \n[pubs.acs.org/jpr](pubs.acs.org/jpr)  Article   \nMPOInt: An Epigenetics-Driven Workflow for Integrative Multi-Level Proteomics  \nZoe Schaefer, Carleigh Coffin Sokolik, and Ivana K. Parker *  \n Cite This: J. Proteome Res. 2026, 25, 3304−3317  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Proteomics provides key insights into systems regulating cell behavior and can elucidate key epigenetic states influencing biological functions in health and disease. Integrating different modalities of proteomics (total, phospho, epi) allows for a comprehensive understanding of how systems change in response to a stimulus. A current limitation is that these data are often captured individually with a limited scope of how systems regulating biological processes interact. Integrative analyses are essential to accurately depict biological states but often require custom, time-consuming bioinformatics processing. The MPOInt pipeline and its associated R package provide highly flexible analysis modules that can be easily combined to develop a  \nmultidimensional view of the input data with minimal barrier to entry, and is capable of integrating histone proteome data with known epigenetic effectors. Using this tool and pre-existing clinical data, we identify several pathways that may be targets in driving the growth of aggressive cancers, including treatment-resistant estrogen receptor-positive breast cancer. Overall, MPOInt adds clinical context to data that is traditionally difficult to interpret and generates a unique network centered around epigenetic factors for each collection of data.  \nKEYWORDS: proteomics, epigenetics, epiproteome, phosphoproteomics, BCG, MCF-7, histone, disease enrichment, bladder cancer, breast cancer  \n■ INTRODUCTION  \nProteomics has emerged as an essential tool in systems biology. New methods are being developed every year that increase the information able to be extracted from a single sample. Many of these methods focus on a single proteomic level, indicating a unique type of protein to be analyzed. Proteomics as an umbrella term describes the study of all proteins in a sample, which can vary in composition from cell culture lysate,1,2 to biological fluids such as urine3,4 or blood,5−7 to tissue biopsies8−10 from patients. Emerging technologies allow for absolute and relative quantification of targeted peptides in each sample. 11−13  \nProteomics enables the identification and targeting of proteins based on unique properties, such as post-translational modifications (PTMs) or cellular location and function. This approach facilitates the targeted identification of specific protein subsets within a sample that possess distinct regulatory functions. For example, phosphoproteomics identifies phosphorylated proteins that are enriched by leveraging properties of negatively charged phosphate groups. 14, 15 Common methods include immobilized metal affinity chromatography (IMAC) or titanium dioxide columns, which use positively charged metal ions to bind phosphate groups.16, 17 Phosphorylated proteins can then be eluted separately from the rest ofthe sample. Similar techniques exist for other post-translational modifications (PTMs), including acetylation and acetylomics18, 19 as well as ubiquitination and ubiquitinomics.20,21  \n© 2026 The Authors. Published by American Chemical Society  \nCellular compartments and protein types also have distinct proteomic subsets: exosome proteomics looks at extracellular vesicles,22,23 while epiproteomics examines histones and their associated PTMs.24 While techniques for obtaining this information continue to evolve,25 few tools exist to connect each proteomic level.  \nProteomics data is inherently large-scale, identifying thousands of peptides per scan. Databases such as the PRIDE Archive store tens of thousands of data ","cbCaih1yuR0vL1q3","https://ap.wps.com/l/cbCaih1yuR0vL1q3","pdf",4148080,14,"English","# Introduction\n## Proteomics in systems biology and proteomic levels\n## Targeting proteins via PTMs and quantification approaches\n## Data scale, repositories, and the need for integrative tools\n## Epigenetic landscape and limitations of isolated proteomics datasets","[{\"question\":\"What problem does the MPOInt workflow address in proteomics research?\",\"answer\":\"It addresses the limitation that proteomics data are often collected in separate modalities with limited insight into how regulatory systems interact, and that integrative analysis typically requires custom, time-consuming bioinformatics.\"},{\"question\":\"How does MPOInt integrate multiple proteomics modalities?\",\"answer\":\"It combines total, phospho, and epi proteomics into a multi-dimensional view and can integrate histone proteome data with known epigenetic effectors using its flexible pipeline modules and associated R package.\"},{\"question\":\"How can MPOInt use clinical data to support biological discovery?\",\"answer\":\"By applying the tool to pre-existing clinical datasets, it identifies pathways that may be targets in driving aggressive cancers, including treatment-resistant estrogen receptor-positive breast cancer, and produces epigenetic-centered networks for each dataset.\"}]","MPOInt: An Epigenetics-Driven Workflow for Integrative Multi-Level Proteomics | PDF",1790083315,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83db96f66e83a27ac3901b8b32fc60ba.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ee8e9452338b2a2327092c627181159.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bb0d07c44712f5640da38d8b7ef149e.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3806a1b1e7d9f9e05fe9f81fe49860d2.webp",980,1292]